MAY 7, 2010; Direct Strategy completes investment in Somanetics

MAY 7, 2010: Somanetics Corporation develops, manufactures, and markets the INVOS® Cerebral/Somatic Oximeter. It is a noninvasive, safe and effective oxygen monitor for adults, children, infants and neonates in any clinical setting. "Somanetics brings a proprietary cerebral platform which is aligned with Direct Strategy investment criteria", said Antonio De La Rosa, Managing Director of Direct Strategy.

Direct Strategy  |  8777 North Gainey Center  |  Suite 136 Scottsdale, AZ 85258  |  Direct Strategy 2008 All Rights Reserved.